Search

Your search keyword '"DI ROCCO, M"' showing total 760 results
Start Over Author "DI ROCCO, M"
760 results on '"DI ROCCO, M"'

1. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

Author

Biegstraaten, M., Cox, T.M., Belmatoug, N., Berger, M.G., Collin-Histed, T., Vom Dahl, S., Di Rocco, M., Fraga, C., Giona, F., Giraldo, P., Hasanhodzic, M., Hughes, D.A., Iversen, P.O., Kiewiet, A.I., Lukina, E., Machaczka, M., Marinakis, T., Mengel, E., Pastores, G.M., Plöckinger, U., Rosenbaum, H., Serratrice, C., Symeonidis, A., Szer, J., Timmerman, J., Tylki-Szymańska, A., Weisz Hubshman, M., Zafeiriou, D.I., Zimran, A., and Hollak, C.E.M.

Published
2018
Full Text
View/download PDF

3. Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus

Author

Scarpa, M, Barbato, A, Bisconti, A, Burlina, A, Concolino, D, Deodato, F, Di Rocco, M, Dionisi-Vici, C, Donati, M, Fecarotta, S, Fiumara, A, Galeone, C, Giona, F, Giuffrida, G, Manna, R, Mariani, P, Pession, A, Scopinaro, A, Spada, M, Spandonaro, F, Trifirò, G, Carubbi, F, Cappellini, M, Scarpa, Maurizio, Barbato, Antonio, Bisconti, Annalisa, Burlina, Alberto, Concolino, Daniela, Deodato, Federica, Di Rocco, Maja, Dionisi-Vici, Carlo, Donati, Maria Alice, Fecarotta, Simona, Fiumara, Agata, Galeone, Carlotta, Giona, Fiorina, Giuffrida, Gaetano, Manna, Raffaele, Mariani, Paolo, Pession, Andrea, Scopinaro, Annalisa, Spada, Marco, Spandonaro, Federico, Trifirò, Gianluca, Carubbi, Francesca, Cappellini, Maria Domenica, Scarpa, M, Barbato, A, Bisconti, A, Burlina, A, Concolino, D, Deodato, F, Di Rocco, M, Dionisi-Vici, C, Donati, M, Fecarotta, S, Fiumara, A, Galeone, C, Giona, F, Giuffrida, G, Manna, R, Mariani, P, Pession, A, Scopinaro, A, Spada, M, Spandonaro, F, Trifirò, G, Carubbi, F, Cappellini, M, Scarpa, Maurizio, Barbato, Antonio, Bisconti, Annalisa, Burlina, Alberto, Concolino, Daniela, Deodato, Federica, Di Rocco, Maja, Dionisi-Vici, Carlo, Donati, Maria Alice, Fecarotta, Simona, Fiumara, Agata, Galeone, Carlotta, Giona, Fiorina, Giuffrida, Gaetano, Manna, Raffaele, Mariani, Paolo, Pession, Andrea, Scopinaro, Annalisa, Spada, Marco, Spandonaro, Federico, Trifirò, Gianluca, Carubbi, Francesca, and Cappellini, Maria Domenica

Abstract

Acid sphingomyelinase deficiency (ASMD) is an ultra-rare disease, and several gaps of knowledge on various issues remain, particularly at a regional/national level. Expert opinions collected through well-defined consensus methodologies are increasingly used to make available reliable information in the context of rare/ultra-rare diseases. With the aim to provide indications on infantile neurovisceral ASMD (also formerly known as Niemann–Pick disease type A), chronic neurovisceral ASMD (formerly known as Niemann–Pick disease type A/B) and chronic visceral ASMD (formerly known as Niemann–Pick disease type B) in Italy, we conducted a Delphi consensus of experts focused on five main areas: (i) patients and disease characteristics; (ii) unmet needs and quality of life; (iii) diagnostic issues; (iv) treatment-related aspects; and (v) patient journey. Pre-specified, objective criteria were used to outline the multidisciplinary panel, based on 19 Italian experts in ASMD in paediatric and adult patients from different Italian Regions, including both clinicians (n = 16) and ASMD patients’ advocacy or payors with expertise in rare diseases (n = 3). During two Delphi rounds, a high ratio of agreement was found on several topics related to ASMD characteristics, diagnosis, management and disease burden. Our findings may provide valuable indications for management of ASMD at a public health level in Italy.

Published
2023

4. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia

Author

Pession, A., Di Rocco, M., Venturelli, F., Tappino, B., Morello, W., Santoro, N., Giordano, P., Filippini, B., Rinieri, S., Russo, G., Girardi, K., Ruggiero, A., Galea, E., Antonucci, R., Tovaglieri, N., Porta, F., Tartaglione, I., Giona, F., Fagioli, F., Burlina, A., Mura, R., Russo, B., Tornesello, A., Menna, G., Russo, D., Caniglia, M., Schettini, S., Onofrillo, D., Ladogana, S., and Civino, A.

Subjects
Cytopenia, Splenomegaly, Lysosomal storage disease, Gaucher disease, Thrombocytopenia
Published
2023

6. Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhood

Author

Bertamino, M., Signa, S., Veneruso, M., Prato, G., Caorsi, R., Losurdo, G., Teutonico, F., Esposito, S., Formica, F., Tovaglieri, N., Nagel, M. A., Amico, G., Zanetti, A., Tortora, D., Rossi, A., Moretti, P., Gattorno, M., Ravelli, A., Severino, M., Di Rocco, M., Cornaglia, S., Tacchino, C., Ceccherini, I., Banov, L., Nobili, L., Palmieri, A., Pavanello, M., Ramenghi, L., Ronchetti, A., Uccella, S., and Volpi, S.

Subjects
Male, Pediatrics, medicine.medical_specialty, Neurology, Post varicella stroke, Late recurrence, Vasculopathy, Neuroimaging, Disease, 03 medical and health sciences, symbols.namesake, Chickenpox, 0302 clinical medicine, Recurrence, Risk Factors, Vessel wall imaging, medicine, Humans, Pediatric stroke, 030212 general & internal medicine, Preschool, Child, Children, Stroke, Fisher's exact test, Neuroradiology, First episode, Arterial ischemic stroke, Child, Preschool, Infant, business.industry, medicine.disease, Rash, symbols, Neurology (clinical), medicine.symptom, business, 030217 neurology & neurosurgery
Abstract

Post-varicella arterial ischemic stroke (AIS) is considered an uncommon cause of pediatric stroke that is considered a self-limiting, monophasic disease. However, in a subset of patients, disease recurs; the prevalence of vasculopathy or AIS recurrence, severity of clinical outcomes, and standardized therapies have not been well characterized. Herein, we determined the clinical-neuroradiological features, long-term evolution, and relationship between acute phase treatment and vasculopathy recurrence in a pediatric population with post-varicella AIS. Clinical, laboratory, and neuroradiological features of 22 children with post-varicella AIS between 2010 and 2019 (16 males, mean age at stroke 4 years, range 1.7–10) were reviewed. Statistical analyses were performed using χ2 and Fisher exact tests. Of the 22 cases, mean time from varicella to stroke was 4.5 months with 3 cases presenting more than 12 months after rash; 21 (95%) were not vaccinated for varicella; 3 (13.6%) had posterior circulation involvement; and 5 (22.7%) had AIS or vasculopathy recurrence, of which 4 recurred 6.1 months to 2.8 years after initial clinical onset. Recurrence was associated with lack of antiviral treatment during the first episode (p = 0.02). Post-varicella AIS can occur months after rash making diagnosis challenging. Because recurrent vasculopathy was seen predominantly in cases not treated with antiviral therapy during initial presentation, it is important to rapidly diagnose post-varicella AIS through clinical criteria and/or virological testing then treat with antivirals to prevent recurrence.

Published
2021
Full Text
View/download PDF

8. Robotic Ubiquitous Cognitive Ecology for Smart Homes

Author

Amato, G., Bacciu, D., Broxvall, M., Chessa, S., Coleman, S., Di Rocco, M., Dragone, M., Gallicchio, C., Gennaro, C., Lozano, H., McGinnity, T. M., Micheli, A., Ray, A. K., Renteria, A., Saffiotti, A., Swords, D., Vairo, C., and Vance, P.

Published
2015
Full Text
View/download PDF

11. Molecular genetics of niemann–pick type c disease in italy: An update on 105 patients and description of 18 NPC1 novel variants

Author

Dardis, A, Zampieri, S, Gellera, C, Carrozzo, R, Cattarossi, S, Peruzzo, P, Dariol, R, Sechi, A, Deodato, F, Caccia, C, Verrigni, D, Gasperini, S, Fiumara, A, Fecarotta, S, Carecchio, M, Filosto, M, Santoro, L, Borroni, B, Bordugo, A, Brancati, F, Russo, C, Di Rocco, M, Toscano, A, Scarpa, M, Bembi, B, Dardis A., Zampieri S., Gellera C., Carrozzo R., Cattarossi S., Peruzzo P., Dariol R., Sechi A., Deodato F., Caccia C., Verrigni D., Gasperini S., Fiumara A., Fecarotta S., Carecchio M., Filosto M., Santoro L., Borroni B., Bordugo A., Brancati F., Russo C. V., Di Rocco M., Toscano A., Scarpa M., Bembi B., Dardis, A, Zampieri, S, Gellera, C, Carrozzo, R, Cattarossi, S, Peruzzo, P, Dariol, R, Sechi, A, Deodato, F, Caccia, C, Verrigni, D, Gasperini, S, Fiumara, A, Fecarotta, S, Carecchio, M, Filosto, M, Santoro, L, Borroni, B, Bordugo, A, Brancati, F, Russo, C, Di Rocco, M, Toscano, A, Scarpa, M, Bembi, B, Dardis A., Zampieri S., Gellera C., Carrozzo R., Cattarossi S., Peruzzo P., Dariol R., Sechi A., Deodato F., Caccia C., Verrigni D., Gasperini S., Fiumara A., Fecarotta S., Carecchio M., Filosto M., Santoro L., Borroni B., Bordugo A., Brancati F., Russo C. V., Di Rocco M., Toscano A., Scarpa M., and Bembi B.

Abstract

Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes. In 2009, the molecular characterization of 44 NPC Italian patients has been published. Here, we present an update of the genetic findings in 105 Italian NPC patients belonging to 83 unrelated families (77 NPC1 and 6 NPC2). NPC1 and NPC2 genes were studied following an algorithm recently published. Eighty-four different NPC1 and five NPC2 alleles were identified. Only two NPC1 alleles remained non detected. Sixty-two percent of NPC1 alleles were due to missense variants. The most frequent NPC1 mutation was the p.F284Lfs*26 (5.8% of the alleles). All NPC2 mutations were found in the homozygous state, and all but one was severe. Among newly diagnosed patients, 18 novel NPC1 mutations were identified. The pathogenic nature of 7/9 missense alleles and 3/4 intronic variants was confirmed by filipin staining and NPC1 protein analysis or mRNA expression in patient’s fibroblasts. Taken together, our previous published data and new results provide an overall picture of the molecular characteristics of NPC patients diagnosed so far in Italy.

Published
2020

32. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum

Author

Motta, M., Pannone, L., Pantaleoni, F., Bocchinfuso, G., Radio, F. C., Cecchetti, S., Ciolfi, A., Di Rocco, M., Elting, M. W., Brilstra, E. H., Boni, S., Mazzanti, L., Tamburrino, F., Walsh, L., Payne, K., Fernandez-Jaen, A., Ganapathi, M., Chung, W. K., Grange, D. K., Dave-Wala, A., Reshmi, S. C., Bartholomew, D. W., Mouhlas, D., Carpentieri, G., Bruselles, A., Pizzi, S., Bellacchio, E., Piceci-Sparascio, F., Lissewski, C., Brinkmann, J., Waclaw, R. R., Waisfisz, Q., van Gassen, K., Wentzensen, I. M., Morrow, M. M., Alvarez, S., Martinez-Garcia, M., De Luca, A., Memo, L., Zampino, Giuseppe, Rossi, C., Seri, M., Gelb, B. D., Zenker, M., Dallapiccola, B., Stella, L., Prada, C. E., Martinelli, S., Flex, E., Tartaglia, M., Zampino G. (ORCID:0000-0003-3865-3253), Motta, M., Pannone, L., Pantaleoni, F., Bocchinfuso, G., Radio, F. C., Cecchetti, S., Ciolfi, A., Di Rocco, M., Elting, M. W., Brilstra, E. H., Boni, S., Mazzanti, L., Tamburrino, F., Walsh, L., Payne, K., Fernandez-Jaen, A., Ganapathi, M., Chung, W. K., Grange, D. K., Dave-Wala, A., Reshmi, S. C., Bartholomew, D. W., Mouhlas, D., Carpentieri, G., Bruselles, A., Pizzi, S., Bellacchio, E., Piceci-Sparascio, F., Lissewski, C., Brinkmann, J., Waclaw, R. R., Waisfisz, Q., van Gassen, K., Wentzensen, I. M., Morrow, M. M., Alvarez, S., Martinez-Garcia, M., De Luca, A., Memo, L., Zampino, Giuseppe, Rossi, C., Seri, M., Gelb, B. D., Zenker, M., Dallapiccola, B., Stella, L., Prada, C. E., Martinelli, S., Flex, E., Tartaglia, M., and Zampino G. (ORCID:0000-0003-3865-3253)

Abstract

Signal transduction through the RAF-MEK-ERK pathway, the first described mitogen-associated protein kinase (MAPK) cascade, mediates multiple cellular processes and participates in early and late developmental programs. Aberrant signaling through this cascade contributes to oncogenesis and underlies the RASopathies, a family of cancer-prone disorders. Here, we report that de novo missense variants in MAPK1, encoding the mitogen-activated protein kinase 1 (i.e., extracellular signal-regulated protein kinase 2, ERK2), cause a neurodevelopmental disease within the RASopathy phenotypic spectrum, reminiscent of Noonan syndrome in some subjects. Pathogenic variants promote increased phosphorylation of the kinase, which enhances translocation to the nucleus and boosts MAPK signaling in vitro and in vivo. Two variant classes are identified, one of which directly disrupts binding to MKP3, a dual-specificity protein phosphatase negatively regulating ERK function. Importantly, signal dysregulation driven by pathogenic MAPK1 variants is stimulus reliant and retains dependence on MEK activity. Our data support a model in which the identified pathogenic variants operate with counteracting effects on MAPK1 function by differentially impacting the ability of the kinase to interact with regulators and substrates, which likely explains the minor role of these variants as driver events contributing to oncogenesis. After nearly 20 years from the discovery of the first gene implicated in Noonan syndrome, PTPN11, the last tier of the MAPK cascade joins the group of genes mutated in RASopathies.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results